LoBuglio; Albert F

Patent Applications and Registrations

Patent applications and USPTO patent grants for LoBuglio; Albert F.The latest application filed is for "method of treating breast cancer".

Company Profile

1.10.14

LoBuglio; Albert F - Birmingham AL
LoBuglio; Albert F. - Birmingham AL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Treating Breast Cancer App 20190375806 - VARLEY; Katherine E ; et al.	2019-12-12
Treating basal-like genotype cancers Grant 10,316,100 - Buchsbaum , et al.	2019-06-11
Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof App 20170267733 - Varley; Katherine E. ; et al.	2017-09-21
Treating basal-like genotype cancers Grant 9,527,915 - Buchsbaum , et al. December 27, 2	2016-12-27
Treating Basal-Like Genotype Cancers App 20160317551 - Buchsbaum; Donald J. ; et al.	2016-11-03
Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof App 20140162296 - Varley; Katherine E. ; et al.	2014-06-12
Targeting cancer stem cells with DR5 agonists Grant 8,703,712 - Buchsbaum , et al. April 22, 2	2014-04-22
Targeting Cancer Stem Cells App 20130004521 - Buchsbaum; Donald J. ; et al.	2013-01-03
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,981,421 - Zhou , et al. July 19, 2	2011-07-19
Treating Basal-Like Genotype Cancers App 20110104143 - Buchsbaum; Donald J. ; et al.	2011-05-05
Combinations Of Antibodies Selective For Dr5 And Other Therapeutic Agents App 20110002887 - Kimberly; Robert P. ; et al.	2011-01-06
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,704,502 - Zhou , et al. April 27, 2	2010-04-27
Antibody Selective For Dr4 And Uses Thereof App 20090208483 - Zhou; Tong ; et al.	2009-08-20
Combinations of Antibodies Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Other Therapeutic Agents App 20090022707 - Kimberly; Robert P. ; et al.	2009-01-22
Antibody selective for DR4 and uses thereof Grant 7,476,383 - Zhou , et al. January 13, 2	2009-01-13
Combinations of DR5 antibodies and other therapeutic agents Grant 7,279,160 - Zhou , et al. October 9, 2	2007-10-09
Melanoma antigens and methods of use App 20040136999 - Strong, Theresa ; et al.	2004-07-15
Melanoma antigens and methods of use Grant 6,677,444 - Strong , et al. January 13, 2	2004-01-13
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof App 20030198637 - Zhou, Tong ; et al.	2003-10-23
Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents App 20030133932 - Zhou, Tong ; et al.	2003-07-17

Company Registrations

NCAGE Code	48P74	LOBUGLIO ALBERT F
CAGE Code	48P74	LOBUGLIO, ALBERT F
DUNS	613001994	LOBUGLIO, ALBERT F

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.